| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.08 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |